logo

For the Inventor, By the Inventor

Indianapolis, IN, United States of America

Eli Lilly and Company


USPTO Granted Patents = 4,443



Trademarks = 608

Forward Citations = 55,484

Loading Chart...
Loading Chart...

3,288 inventors (with patents filed for the assignee):

goldMedal George J Cullinan (106 out of 109 patents)

silverMedal John M Schaus (97 out of 101 patents)

bronzeMedal Henry U Bryant (83 out of 84 patents)

4.  Charles David Jones (75 out of 99 patents)

5.  Jeffrey A Dodge (74 out of 74 patents)

6.  Michael Robert Wiley (71 out of 72 patents)

7.  Daniel Jon Sall (70 out of 70 patents)

8.  James E Audia (60 out of 98 patents)

9.  Charles J Paget, Jr (60 out of 61 patents)

10.  Robert L Hamill (58 out of 58 patents)

11.  Alan David Palkowitz (57 out of 59 patents)

12.  Nicholas J Bach (55 out of 56 patents)

13.  Paul Leslie Ornstein (54 out of 54 patents)

14.  Gerald Floyd Smith (54 out of 63 patents)

15.  Jason Scott Sawyer (53 out of 72 patents)


Core Competencies:
Peptide Synthesis
AHR Agonists
Intravenous Fluid Warming
Interleukin-19
Anti-alpha-synuclein Antibodies
GIP/GLP1 Agonists
Cancer Treatment
Sodium-Hydrogen Exchanger Inhibitors
Antibody Drug Conjugates
Incretin Analogs
Medication Delivery Devices
KRas Inhibitors

4,443 patents:

1. 12491160 - Formulations of a farnesoid X receptor agonist (2025-12-09),
2. 12485402 - Three resin reactors in series peptide synthesizer (2025-12-02),
3. 12479829 - 2-[2-methylazetidin-1-yl]-4-phenyl-6-(trifluoromethyl)-pyrimidine compounds (2025-11-25),
4. 12479822 - AHR agonists (2025-11-25),
5. 12478746 - Device and method for intravenous fluid warming (2025-11-25),
6. 12473267 - Process and intermediate for the preparation of oxetan-2-yl-methanamine (2025-11-18),
7. D1101804 - Display screen with animated graphical user interface (2025-11-11),
8. 12459997 - Compounds and methods targeting interleukin-19 (2025-11-04),
9. 12459993 - Anti-alpha-synuclein antibodies and uses thereof (2025-11-04),
10. 12454512 - Processes and intermediates for the preparation of 2-(2,6-dichlorophenyl)-1-[(1S,3R)-3-(hydroxymethyl)-5-(3-hydroxy-3-methylbutyl)-1-methyl-3,4-dihydroisoquinolin-2(1H)-yl]ethenone (2025-10-28),
11. 12454511 - 6-methoxy-3,4-dihydro-1H-isoquinolin compounds (2025-10-28),
12. 12453771 - Methods of treating cancer using anti-CD137 antibodies (2025-10-28),
13. 12453758 - Method of using a GIP/GLP1 co-agonist for diabetes (2025-10-28),
14. 12453756 - GIP/GLP1 agonist compositions (2025-10-28),
15. 12453755 - GIP/GLP1 agonist compositions (2025-10-28),
Eli Lilly and Company is a global pharmaceutical company headquartered in Indianapolis, Indiana. It specializes in the research, development, and production of pharmaceutical products, including treatments for diabetes, cancer, Alzheimer's disease, and other conditions. With a rich heritage of over 140 years, Eli Lilly and Company is committed to improving the health and well-being of people around the world by delivering innovative medicines. Visit their website for more information and details about their products and initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

...
4,443 Patents

#2 in Indianapolis, IN

#2 in Indiana

#97 in US

#205 in the World

...
Indianapolis, IN, United States of America

Eli Lilly and Company

Forward Citations = 55,484

3,288 inventors:

goldMedal George J Cullinan (106 out of 109 patents)

silverMedal John M Schaus (97 out of 101 patents)

bronzeMedal Henry U Bryant (83 out of 84 patents)

4.  Charles David Jones (75 out of 99 patents)

5.  Jeffrey A Dodge (74 out of 74 patents)

Please report any incorrect information to support@idiyas.com
Loading…